DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Trauner M.
The nuclear bile acid receptor FXR as a novel therapeutic target in cholestatic liver diseases: hype or hope?
Hepatology 2004; 40: 260-263
We do not assume any responsibility for the contents of the web pages of other providers.